Hepatitis B can develop in less than 5% of neonates of infected mothers, despite neonatal serovaccination. Most children will develop a chronic hepatitis. Most children are in an immune-tolerant or in an inactive phase. Interferon is the treatment of choice, in the rare cases where it is necessary.
|Number of pages||3|
|Journal||Clinics and Research in Hepatology and Gastroenterology|
|Publication status||Published - Jun 2012|
ASJC Scopus subject areas